IMT-03 CLINICAL TRIAL FOR NEWLY DIAGNOSED MALIGNANT GLIOMA WITH WT1-W10 VACCINATION

OBJECT: Wilms’ tumor 1 (WT1) peptide vaccination is considered a potentially effective therapy against malignant glioma. We conducted a Phase I/II study to investigate the safety and feasibility of novel WT1 peptide (W10) vaccination therapy for patients with newly diagnosed malignant glioma. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawanishi, Yu, Udaka, Keiko, Yawata, Toshio, Nakai, Eiichi, Fukuda, Hitoshi, Fukui, Naoki, Ueba, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213291/
http://dx.doi.org/10.1093/noajnl/vdz039.078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213291/
http://dx.doi.org/10.1093/noajnl/vdz039.078

Ejemplares similares